Editor's Note: This story has been updated with additional quotes from Pear Therapeutics.
The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division Sandoz announced that it is handing sole responsibility for the commercialization of the reSET and reSET-O prescription digital therapeutics back to Pear Therapeutics.
“Pear and Sandoz previously signed...
Atlanta-based Florence Healthcare, a maker of software for clinical trials, has raised $7.1 million in a Series B funding round led by Fulcrum Equity Partners, with additional participation from Atrium Health and Bee Partners.
The round brings the company's total funding to at least $8.8 million, with a $1.7 million seed round from 2016.
WHAT THEY DO
Not to be confused with the UK social care...
Walmart’s 2020 healthcare plan for its retail associates will have some new features courtesy of partnerships with digital and remote health companies.
For starters, those in the Northwest Arkansas, Orlando/Tampa and Dallas/Fort Worth areas will be provided with a “Featured Providers” tool driven by healthcare data firm Embold Health. With this, associates will receive suggestions for local,...
Novartis is teaming up with Microsoft on a new artificial intelligence initiative focused on drug discovery and development. The new efforts will primarily be focused in Novartis’ newly announced AI innovation lab.
As part of the deal Novartis will be employing Microsoft’s AI tools to help its scientist with computational hurdles in life sciences including generative chemistry, image...
Medisafe, maker of a patient-facing app that promotes medication adherence, has completed a large international pilot in which its software improved adherence to a partnered global pharma’s cardiometabolic therapy, MobiHealthNews has learned.
Medisafe said that it was unable to disclose the identify of the international pharma partner, with whom the pilot’s success has resulted in additional...
Sanofi has been active in the digital space this week inking two big deals: one with tech company Abbott and the other with digital platform Happify.
The first partnership with Abbott will combine the medtech company’s FreeStyle Libre, a continuous glucose monitoring system, and the pharma giant’s insulin dosing information to create smart pens and insulin titration apps.
Sanofi is currently...
When it comes to clinical trials, oftentimes the majority of a patient’s experience happens “off stage” in their home or community. For example, medication adherence, or nonadherence, has been a major pitfall in medicine. Studies have found that roughly one in five new prescriptions are never filled, and of those filled up to 50% are taken incorrectly.
Startups have taken notice and the digital...
OptimizeRx, a software company that enables digital health messaging between pharmas and providers, has announced plans to acquire RMDY Health, a SaaS platform designed for digital therapeutics, within the next 30 days.
According to the notice, RMDY shareholders will be receiving $8 million in cash and another $8 million in equity upon the deal’s closure. OptimizeRx said that additional details...
Increasingly, Amazon Alexa and Siri are no longer just a tool for ordering pizza. Voice technology has found its way into healthcare, and now one of the most established industries in the medical world is starting to explore the possibilities of voice: pharma.
“I think voice should be part of a robust ecosystem in which pharma provides treatment information … and things like that,” Kay Bayne,...
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data.
Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...
